Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TQF3510 vs Wegovy for Weight Management in Obese Subjects
NCT06738979Phase 3Completed
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Mar 2025
- Primary completion
- Mar 2026
- Modality
- Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of tqf3510 in obesity, sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Mar 2025; status: completed.
02
Drugs
tqf3510
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06738979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06738979.